BIIB
Biogen Inc. · Healthcare
Head of Development Priya Singhal sold $58K of Biogen Inc.
Sold$57,962
$221.23Price
262Shares
−5%Stake
What BIIB did after the filing
- The stock from Mon, Feb 26 close, $223.71
- −7.7%
- S&P 500, same days
- +3.0%
Measured over 30 trading days, to the Apr 9 close.
Traded Thu, Feb 22. Filed Mon, Feb 26, 2:54 PM ET, during the session. Returns use the Feb 26 close and the Apr 9 close. Not investment advice.